Literature DB >> 29161653

Psychosocial issues of a population approach to high genetic risk identification: Behavioural, emotional and informed choice issues.

David P French1, Anthony Howell2, D Gareth Evans3.   

Abstract

To allow women at high genetic risk of breast cancer to benefit from prevention or early prevention strategies, a screening programme is required to identify them. The present review considers the likelihood of key outcomes that would arise from such a programme, in relation to behavioural, emotional and informed choice outcomes. The likelihood of outcomes in each category is considered in relation to the limited direct evidence and relevant indirect evidence, given the dearth of studies that have directly studied the effects of communication of personal genetic risk of breast cancer. Overall, there is promise that such a programme would have several behavioural benefits, such as good uptake of increased screening in women at high risk but little effect on screening in women at low risk. The available evidence suggests that major adverse effects on emotional outcomes are unlikely. There is very limited evidence in this developing area on the extent to which decisions of women offered breast cancer risk estimation will be fully informed choices. Recommendations are made for increasing benefits and reducing harms of population-wide breast cancer risk estimation in light of current evidence. Key research gaps are identified.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast cancer; Genetic; Psychological impact; Risk communication; Screening

Mesh:

Year:  2017        PMID: 29161653     DOI: 10.1016/j.breast.2017.11.008

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  6 in total

1.  The feasibility of implementing risk stratification into a national breast cancer screening programme: a focus group study investigating the perspectives of healthcare personnel responsible for delivery.

Authors:  David P French; Victoria G Woof; Helen Ruane; D Gareth Evans; Fiona Ulph; Louise S Donnelly
Journal:  BMC Womens Health       Date:  2022-05-02       Impact factor: 2.742

2.  What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420).

Authors:  David P French; Susan Astley; Adam R Brentnall; Jack Cuzick; Richard Dobrashian; Stephen W Duffy; Louise S Gorman; Elaine F Harkness; Fiona Harrison; Michelle Harvie; Anthony Howell; Andrew Jerrison; Matthew Machin; Anthony J Maxwell; Lorna McWilliams; Katherine Payne; Nadeem Qureshi; Helen Ruane; Sarah Sampson; Paula Stavrinos; Emma Thorpe; Fiona Ulph; Tjeerd van Staa; Victoria Woof; D Gareth Evans
Journal:  BMC Cancer       Date:  2020-06-18       Impact factor: 4.430

3.  Women's perceptions of personalized risk-based breast cancer screening and prevention: An international focus group study.

Authors:  Linda Rainey; Anna Jervaeus; Louise S Donnelly; D Gareth Evans; Mattias Hammarström; Per Hall; Yvonne Wengström; Mireille J M Broeders; Daniëlle van der Waal
Journal:  Psychooncology       Date:  2019-03-25       Impact factor: 3.894

4.  Interest in Cancer Predisposition Testing and Carrier Screening Offered as Part of Routine Healthcare Among an Ethnically Diverse Sample of Young Women.

Authors:  Kimberly A Kaphingst; Jemar R Bather; Brianne M Daly; Daniel Chavez-Yenter; Alexis Vega; Wendy K Kohlmann
Journal:  Front Genet       Date:  2022-04-14       Impact factor: 4.772

5.  Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the "My Personal Breast Screening" (MyPeBS) randomised clinical trial.

Authors:  Alexandra Roux; Rachel Cholerton; Jonathan Sicsic; Nora Moumjid; David P French; Paolo Giorgi Rossi; Corinne Balleyguier; Michal Guindy; Fiona J Gilbert; Jean-Benoit Burrion; Xavier Castells; David Ritchie; Debbie Keatley; Camille Baron; Suzette Delaloge; Sandrine de Montgolfier
Journal:  BMC Cancer       Date:  2022-05-06       Impact factor: 4.638

Review 6.  Personalized early detection and prevention of breast cancer: ENVISION consensus statement.

Authors:  Nora Pashayan; Antonis C Antoniou; Urska Ivanus; Laura J Esserman; Douglas F Easton; David French; Gaby Sroczynski; Per Hall; Jack Cuzick; D Gareth Evans; Jacques Simard; Montserrat Garcia-Closas; Rita Schmutzler; Odette Wegwarth; Paul Pharoah; Sowmiya Moorthie; Sandrine De Montgolfier; Camille Baron; Zdenko Herceg; Clare Turnbull; Corinne Balleyguier; Paolo Giorgi Rossi; Jelle Wesseling; David Ritchie; Marc Tischkowitz; Mireille Broeders; Dan Reisel; Andres Metspalu; Thomas Callender; Harry de Koning; Peter Devilee; Suzette Delaloge; Marjanka K Schmidt; Martin Widschwendter
Journal:  Nat Rev Clin Oncol       Date:  2020-06-18       Impact factor: 65.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.